IG ISOLO

[ Education and healthcare educational services, namely, providing training and programs concerning awareness and consequence of hemolysis, the risk of hemolysis occurring in certain patients receiving immunoglobulin infusion therapy and the identification and treatment with intravenous immunoglobulin therapy of patients in whom hemolysis may develop ]

Providing medical and pharmaceutical information to patients and healthcare practitioners, namely, providing medical information regarding hemolysis and the risk of occurrence in and the treatment of certain patients undergoing human intravenous immunoglobulin therapy and providing information relating to the therapeutic properties of pharmaceuticals for the treatment of hemolysis